Highlights Smith & Nephew Plc

Equities

Market Closed - London S.E. Other stock markets 09:05:04 08/05/2024 pm IST			5-day change	1st Jan Change
1,008 ^GBX	+0.97%		+3.16%	-6.58%

03/05	Jefferies cuts AJ Bell; Deutsche likes ConvaTec	AN
02/05	Deutsche Bank likes TP ICAP but says sell CMC	AN

London Stocks Retreat as UK Manufacturing Sector Reverts to Contraction	01/05	MT
Smith & Nephew confident for full-year despite mixed first quarter	01/05	AN
Smith & Nephew Logs Higher Q1 Revenue; FY24 Guidance Affirmed	01/05	MT
Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B	01/05	MT
Smith+Nephew, Navbit Sign Distribution Deal for Hip Replacement Surgical Navigation System in Australia	09/04	MT
Smith+Nephew Introduces the RENASYS EDGE Negative Pressure Wound Therapy System	01/04	CI
London stocks round off March quarter with healthy gains	28/03	RE
Final dividend	28/03	FA
Smith & Nephew Signs Up as Official Partner for UFC	25/03	MT
Smith+Nephew Teams Up with Ufc to Be First-Ever Preferred Sports Medicine Technology Partner	25/03	CI
Smith & Nephew prices USD1 billion in debt notes	14/03	AN
SMITH & NEPHEW : Strong ‘proof of execution’ to end FY23	29/02
Smith & Nephew Signs Research Deal With US Army Institute of Surgical Research	28/02	MT
Smith & Nephew 2023 Adjusted Earnings, Revenue Rise	27/02	MT
Smith & Nephew plc Recommends Final Dividend for 2023, Payable on May 22, 2024	27/02	CI
Smith & Nephew plc Provides Earnings Guidance for 2024	27/02	CI
British investors await key economic data amid cautious trading	27/02
Smith & Nephew revenue and profit rise; keeps dividend unchanged	27/02	AN
Croda profit slumps amid weak market, destocking	27/02	AN
Smith & Nephew Posts Higher FY23 Attributable Profit, Revenue	27/02	MT

No results for this search

SMITH & NEPHEW : Strong ‘proof of execution’ to end FY23

February 29, 2024 at 06:22 pm IST